Trial intelligence / Profile preview

Sertindole versus risperidone safety outcome study

2004-000213-19Phase 4Completed

Sponsor
Lundbeck
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in schizophrenia comparing Sertindole arm with Risperidone arm (2 arms). Primary endpoint: Primary safety outcome. Started Feb 2005; status: completed.

02

Drugs

sertindolerisperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2004-000213-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-000213-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call